A public-private partnership to enhance the botanical safety toolkit

Botanical dietary supplement and herbal medicine use is increasing both in the United States and worldwide. Products made from botanicals can be variable in chemical composition, with many aspects affecting their quantitative and qualitative chemical content and unknown impacts on potential toxicity profiles. Many regulatory structures do not currently require toxicity data and only require…

Read More

Botanical researchers aim to fill gap in safety testing

Of the approximately 28,000 plants that have medicinal properties, only a few have been assessed for safety. Scientists discussed an ambitious effort to fill that gap at the first public meeting of the Botanical Safety Consortium (BSC) on May 29. [BSC seeks to] enhance the botanical safety toolkit and bring clarity to botanical dietary ingredient assessments for…

Read More

Botanical Safety Taken on by New Consortium (NIH Record)

Looking to address concerns about the safety of botanicals, NIEHS joined forces with FDA and the nonprofit Health and Environmental Sciences Institute (HESI) to form the Botanical Safety Consortium, through a recent memorandum of understanding. The group serves as a collaborative forum on botanical safety research, drawing global scientists from government, academia, consumer health groups,…

Read More

Botanical safety taken on by new consortium

Looking to address concerns about the safety of botanicals, NIEHS joined forces with the U.S. Food and Drug Administration (FDA) and the nonprofit Health and Environmental Sciences Institute (HESI) to form the Botanical Safety Consortium. The consortium, which launched a website in March, will serve as a collaborative forum on botanical safety research. The group hopes to draw global…

Read More

FDA: Botanical Safety Consortium Formally Convened

Silver Spring, MD—The U.S. Food and Drug Administration (FDA) announced in a constituent update that the Botanical Safety Consortium (BSC) has formally been convened. Calling it a “milestone,” FDA said the BSC is the result of a Memorandum of Understanding (MOU) that  between the FDA, the National Institutes of Health’s National Institute of Environmental Health Sciences, and the Health and Environmental Sciences Institute…

Read More

FDA convenes the Botanical Safety Consortium

The U.S. Food and Drug Administration (FDA) has announced that the Botanical Safety Consortium (BSC) has formally been convened. This milestone is the result of a Memorandum of Understanding (MOU) that was recently signed between the FDA, the National Institutes of Health’s National Institute of Environmental Health Sciences, and the Health and Environmental Sciences Institute…

Read More

Botanical Safety Consortium Formally Convenes

Following the recent signing of a Memorandum of Understanding (MOU) between the FDA, the National Institutes of Health’s National Institute of Environmental Health Sciences, and the Health and Environmental Sciences Institute (HESI), the Botanical Safety Consortium (BSC) has formally been convened, establishing its framework. Read full article here

Read More